- Home
- CETY vs SYBX Comparison
CETY vs SYBX Comparison
Compare CETY & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CETY
- SYBX
- Stock Information
- Founded
- CETY 1993
- SYBX N/A
- Country
- CETY United States
- SYBX United States
- Employees
- CETY N/A
- SYBX N/A
- Industry
- CETY Power Generation
- SYBX Biotechnology: Pharmaceutical Preparations
- Sector
- CETY Utilities
- SYBX Health Care
- Exchange
- CETY Nasdaq
- SYBX Nasdaq
- Market Cap
- CETY 19.6M
- SYBX 16.4M
- IPO Year
- CETY N/A
- SYBX N/A
- Fundamental
- Price
- CETY $2.52
- SYBX $1.69
- Analyst Decision
- CETY
- SYBX
- Analyst Count
- CETY 0
- SYBX 0
- Target Price
- CETY N/A
- SYBX N/A
- AVG Volume (30 Days)
- CETY 1.5M
- SYBX 17.6K
- Earning Date
- CETY 11-18-2025
- SYBX 11-11-2025
- Dividend Yield
- CETY N/A
- SYBX N/A
- EPS Growth
- CETY N/A
- SYBX N/A
- EPS
- CETY N/A
- SYBX N/A
- Revenue
- CETY $1,743,723.00
- SYBX N/A
- Revenue This Year
- CETY N/A
- SYBX N/A
- Revenue Next Year
- CETY N/A
- SYBX N/A
- P/E Ratio
- CETY N/A
- SYBX N/A
- Revenue Growth
- CETY N/A
- SYBX N/A
- 52 Week Low
- CETY $0.18
- SYBX $0.90
- 52 Week High
- CETY $2.60
- SYBX $1.96
- Technical
- Relative Strength Index (RSI)
- CETY 89.70
- SYBX 56.21
- Support Level
- CETY $0.18
- SYBX $1.61
- Resistance Level
- CETY $3.05
- SYBX $1.74
- Average True Range (ATR)
- CETY 0.09
- SYBX 0.08
- MACD
- CETY 0.22
- SYBX -0.01
- Stochastic Oscillator
- CETY 80.88
- SYBX 41.67
About CETY Clean Energy Technologies Inc.
Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business. It has four segments: Clean Energy HRS & CETY Europe, CETY Renewables Waste to Energy Solutions, Engineering and Manufacturing Business and CETY HK. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.